Руководство к использованию стандарта FHIR в ЦИСЗ
0.2.6803 - ci-build
{
"resourceType" : "Immunization",
"id" : "ExamplePadiatricKDS",
"meta" : {
"profile" : [
🔗 "https://fhir.by/StructureDefinition/ImmunizationBy"
]
},
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/ImmunizationIdentifierType",
"code" : "rec-guid"
}
]
},
"value" : "120"
}
],
"basedOn" : [
{
"reference" : "ExampleRecomendPed"
}
],
"status" : "completed",
"vaccineCode" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportVaccineses",
"code" : "0030",
"display" : "Инфанрикс Гекса 0,5 мл"
}
]
},
"manufacturer" : {
"concept" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportManufacturer",
"code" : "18",
"display" : "GlaxoSmithKline Biologicals, Франция/ GlaxoSmithKline Biologicals s.a., Бельгия"
}
]
}
},
"lotNumber" : "03623",
"expirationDate" : "2026-03-01",
"patient" : {
🔗 "reference" : "Patient/ExamplePediatricPatientWithIdentificationNumber"
},
"encounter" : {
🔗 "reference" : "Encounter/ExampleEncounterAllergy"
},
"occurrenceDateTime" : "2024-03-01T16:30:00Z",
"informationSource" : {
"reference" : {
🔗 "reference" : "Organization/9ad86c36-0f29-428d-b476-c8603a7cdd1f"
}
},
"location" : {
🔗 "reference" : "Location/TherapyUnit"
},
"site" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationSite",
"code" : "5",
"display" : "Бедро правое"
}
]
},
"route" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationRoute",
"code" : "внутримышечный",
"display" : "Внутримышечный"
}
]
},
"doseQuantity" : {
"value" : 0.5,
"unit" : "мл",
"system" : "https://fhir.by/ValueSet/AISReportUnits",
"code" : "2"
},
"performer" : [
{
"actor" : {
🔗 "reference" : "PractitionerRole/3c057f8d-4369-4c5e-86be-f710dff3a91c"
}
}
],
"reason" : [
{
"concept" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationReason",
"code" : "своевременно",
"display" : "Своевременно"
}
]
}
}
],
"fundingSource" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportFundingSource",
"code" : "False",
"display" : "Бесплатно"
}
]
},
"reaction" : [
{
"manifestation" : {
"concept" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportReaction30Min",
"code" : "no",
"display" : "Нет"
}
]
}
}
}
],
"protocolApplied" : [
{
"extension" : [
{
"url" : "https://fhir.by/StructureDefinition/VaccinationType",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportVaccinationType",
"code" : "вакцинация1",
"display" : "Вакцинация 1"
}
]
}
}
],
"targetDisease" : [
{
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationTargetDiseases",
"code" : "6",
"display" : "гемофильная инфекция"
}
]
},
{
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationTargetDiseases",
"code" : "11",
"display" : "дифтерия"
}
]
},
{
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationTargetDiseases",
"code" : "15",
"display" : "коклюш"
}
]
},
{
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationTargetDiseases",
"code" : "25",
"display" : "столбняк"
}
]
},
{
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationTargetDiseases",
"code" : "8",
"display" : "гепатит В"
}
]
},
{
"coding" : [
{
"system" : "https://fhir.by/ValueSet/AISReportImmunizationTargetDiseases",
"code" : "21",
"display" : "полиомиелит"
}
]
}
],
"doseNumber" : "Вакцинация 1",
"seriesDoses" : "Для достижения иммунитета против гемофильной инфекции следует выполнить ещё 2 дозы; против дифтерии - 6 доз и далее каждые 10 лет; против коклюша - 4 дозы; против столбняка - 5 доз и далее каждые 10 лет; против гепатита В - 2 дозы; против полиомиелита - 3 дозы; против пневмококковой инфекции - 2 дозы"
}
]
}